These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum. Yuthavong Y; Vilaivan T; Chareonsethakul N; Kamchonwongpaisan S; Sirawaraporn W; Quarrell R; Lowe G J Med Chem; 2000 Jul; 43(14):2738-44. PubMed ID: 10893311 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives. Mwande Maguene G; Lekana-Douki JB; Mouray E; Bousquet T; Grellier P; Pellegrini S; Toure Ndouo FS; Lebibi J; Pélinski L Eur J Med Chem; 2015 Jan; 90():519-25. PubMed ID: 25486423 [TBL] [Abstract][Full Text] [Related]
11. 3-alkylthio-1,2,4-triazine dimers with potent antimalarial activity. Ban K; Duffy S; Khakham Y; Avery VM; Hughes A; Montagnat O; Katneni K; Ryan E; Baell JB Bioorg Med Chem Lett; 2010 Oct; 20(20):6024-9. PubMed ID: 20822904 [TBL] [Abstract][Full Text] [Related]
12. 4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents. Kumar A; Srivastava K; Kumar SR; Siddiqi MI; Puri SK; Sexana JK; Chauhan PM Eur J Med Chem; 2011 Feb; 46(2):676-90. PubMed ID: 21194812 [TBL] [Abstract][Full Text] [Related]
13. Preparation, biological & cheminformatics-based assessment of N Toviwek B; Phuangsawai O; Konsue A; Hannongbua S; Riley J; Mutter N; Anderson M; Webster L; Hallyburton I; Read KD; Gleeson MP Bioorg Med Chem; 2021 Sep; 46():116348. PubMed ID: 34479064 [TBL] [Abstract][Full Text] [Related]
14. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase. Srinivasan B; Tonddast-Navaei S; Skolnick J Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and Antiplasmodial Evaluation of Analogues Based on the Tricyclic Core of Thiaplakortones A-D. Schwartz BD; Coster MJ; Skinner-Adams TS; Andrews KT; White JM; Davis RA Mar Drugs; 2015 Sep; 13(9):5784-95. PubMed ID: 26389920 [TBL] [Abstract][Full Text] [Related]
16. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely. Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368 [TBL] [Abstract][Full Text] [Related]
17. Antiplasmodial activity of a series of 1,3,5-triazine-substituted polyamines. Klenke B; Barrett MP; Brun R; Gilbert IH J Antimicrob Chemother; 2003 Aug; 52(2):290-3. PubMed ID: 12837742 [TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents. Tiwari MK; Coghi P; Agrawal P; Shyamlal BRK; Jun Yang L; Yadav L; Peng Y; Sharma R; Yadav DK; Sahal D; Kam Wai Wong V; Chaudhary S ChemMedChem; 2020 Jul; 15(13):1216-1228. PubMed ID: 32392362 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity in vitro. Mishra N; Arora P; Kumar B; Mishra LC; Bhattacharya A; Awasthi SK; Bhasin VK Eur J Med Chem; 2008 Jul; 43(7):1530-5. PubMed ID: 17977622 [TBL] [Abstract][Full Text] [Related]